Schering Korea sold 89.8 BW of sales in 2005.

Published: 2006-04-10 06:56:00

Updated: 2006-04-10 06:56:00

Schering Korea reported the 2005 business performance at 89,885 MW of sales (8.7% up from the previous year), 6,693 MW of operating income (18.5% up), 5,600 MW of ordinary income (a rise compared to 3,374 MW in 2004) and 2,719 MW of net income (188.1% up).

The company equity as of the end of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK